1Dept of Pathology, Imam Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2Thrombosis Homeostasis Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Abstract
It is estimated that the number of HIV infected children globally has increased from 1.6 million in 2001 to 3.3 million in 2012. The number of children below 15 years of age living with HIV has increased worldwide. Published data from recent studies confirmed dramatic survival benefit for infants started anti-retroviral therapy (ART) as early as possible after diagnosis of HI. Early confirmation of HIV diagnosis is required in order to identify infants who need immediate ART. WHO has designed recommendations to improve programs for both early diagnoses of HIV infection and considering ART whenever indicated? It is strongly recommended that HIV virologocal assays for diagnosis of HIV have sensitivity of at least 95% and ideally greater than 98% and specificity of 98% or more under standardized and validated conditions. Timing of virological testing is also important. Infants infected at or around delivery may take short time to have detectable virus. Therefore, sensitivity of virological tests is lower at birth. In utero HIV infection, HIV DNA or RNA can be detected within 48 h of birth and in infants with peripartum acquisition it needs one to two weeks. Finally it is emphasized that all laboratories performing HIV tests should follow available services provided by WHO or CDC for quality assurance programs. Both clinicians and staffs providing laboratory services need regular communications, well-defined SOPs and nationally validated algorithms for optimal use of laboratory tests. Every country should use assays that have been validated by national reference laboratory.
Janssens B, Raleigh B, Soeung S, Akao K, Te V, Gupta J, et al. Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics 2007; 120(5):e1134-40.
Chiappini E, Galli L, Tovo PA, Gabiano C, Gattinara GC, Guarino A, et al. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS, 2006, 20(2):207–215.
Kline MW, Lewis DE, Hollinger FB, Reuben JM, Hanson LC, Kozinetz CA,et al. A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J 1994; 13(2):90-4.
Kovacs A, Xu J, Rasheed S, Li XL, Kogan T, Lee M, Liu C, et al. Comparison of a rapid nonisotopic polymerase chain reaction assay with four commonly used methods for the early diagnosis of human immunodeficiency virus type 1 infection in neonates and children. Pediatr Infect Dis J 1995; 14(11):948-54.
Ribas SG, Ondoa P, Schüpbach J, van der Groen G, Fransen K.et al. Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals. J Virol Methods 2003; 113(1):29-34.
Luo W, Yang H, Rathbun K, Pau CP, Ou CY.et al. Detection of human immunodeficiency virus type 1 DNA in dried blood spots by a duplex real-time PCR assay. J Clin Microbiol 2005; 43(4):1851-7.
Fischer A, Lejczak C, Lambert C, Servais J, Makombe N, Rusine J, et al. Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda. J Clin Microbiol 2004; 42(1):16-20.
Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline GroupMeeting. Geneva, World Health Organization, 2008 (http://www.who.int/hiv/pub/paediatric/WHO_Paediatric_ART_guideline_rev_mreport_2008.pdf).
WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, World HealthOrganization, 200 (http://whqlibdoc.who.int/publications/2007/9789241595629_eng.pdf).
Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva, World Health Organization, 2007 (http://whqlibdoc.who.int/publications/2007/9789241595568_eng.pdf).
World Health Organization and Joint United Nations Programme on HIV/AIDS (UNAIDS). HIV assays: operational characteristics. Geneva, World Health Organization, 2009 (http://www.who.int/diagnostics_laboratory/evaluations/hiv/en/index.html accessed on 18 December 2009).
Antiretroviral Therapy for HIV infection in infants and children: Toward universal access Recommendations for a public health approach, 2010 Revision .WHO.
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection National Institutes of Health, USA, August 16, 2010.
Garrido C, Zahonero N, Corral A, Arredondo M, Soriano V, de Mendoza C.et al. Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott Real Time HIV load tests. J Clin Microbiol 2009; 47(4):1031-6.
Mwaba P, Cassol S, Nunn A, Pilon R, Chintu C, Janes M, et al. Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients. Lancet 2003 20; 362(9401):2067-8.
Braun J, Plantier JC, Hellot MF, Tuaillon E, Gueudin M, Damond F, et al. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS 2003 14; 17(3):331-6.
Frizzera Dias C, Moreira-Silva SF, Reis MA, Ribeiro Patrício L, Biancardi Gavioli CF, Miranda AE. Late diagnosis and HIV infection in children attending a service of specialized care for pediatric AIDS in Brazil. Rev Soc Bras Med Trop 2014 Jan-Feb;47(1):93-6.
HIV Paediatric Prognostic Markers Collaborative Study. Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children. AIDS 2006, 20(9):1289–1294.
Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization. AIDS epidemic update: December 2009. Geneva, Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2009 (http://whqlibdoc.who.int/unaids/2009/9789291738328_eng.pdf).
Schüpbach J.Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA. AIDS Rev 2002; 4(2):83-92.
Zijenah LS, Tobaiwa O, Rusakaniko S, Nathoo KJ, Nhembe M, Matibe P, et al. Signal-boosted qualitative ultrasensitive p24 antigen assay for diagnosis of subtype C HIV-1 infection in infants under the age of 2 years. J Acquir Immune Defic Syndr 2005 1; 39(4):391-4.